Anixa Biosciences Inc (ANIX) Actualités

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 PR...

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset PR Newswire SAN...

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial PR Newswire SAN...

Form 8-K - Current report

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer...

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer...

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024 PR Newswire SAN JOSE, Calif., Oct. 31, 2024...

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine...

Form 4 - Statement of changes in beneficial ownership of securities

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial PR...

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development PR Newswire SAN JOSE...

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial PR Newswire SAN JOSE, Calif...

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine PR Newswire SAN JOSE, Calif., Sept. 24...

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]